Search & Analyze

Shilpa Medicare Ltd.

954.65+19.55 (+2.09%)

BSE · 30 Oct, 4:01 PM

: ₹18,671.22 Cr
: 62.80
: 72,099
: ₹979.00 - ₹930.65
: ₹1,095.65 - ₹260.00

Shilpa Medicare Ltd. (SHILPAMED) share price closed at ₹954.65 on the BSE on Friday, October 30, 2026, up by 2.09% from its of ₹935.10. In that session SHILPAMED reached a of 979.00 and of 930.65. The for the session was 952.21. The stands at 950.92 and is at 583.14. Looking at , the stock ended the session in Uptrend.

Stock Overview

₹956.25

₹935.10

₹952.21

₹950.92

Price 0.39% above

₹583.14

Price 63.71% above

Key Fundamentals

: 18,671.22 Cr₹18.67 Thousand Crore
: 15.20
: 62.80
: 6.95
: 137.34
: 485.92 Cr₹485.92 Crore
: 0.06 %
Sector
Industry: Pharmaceuticals & Drugs
: 9.82
: 0.25

Industry Comparison

Ratio	Company	Sector
	62.80	44.77
	0.25	0.20
	6.95	4.61
	1.31	1.81
	0.06 %	0.11 %
Operating Margin	24.75 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Shilpa Medicare Ltd. SHILPAMED	954.65	62.80	18,671.22	0.06	100.88	115.19%	465.78	44.89%	11.43

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	291.69	292.51	343.80	319.30	330.82	321.47	369.97	409.73	436.99	465.78
Expenses	221.63	218.99	257.79	238.66	251.62	229.84	261.69	295.43	317.28	329.52
	70.06	73.52	86.00	80.65	79.20	91.63	108.28	114.30	119.71	136.26
	24.02%	25.13%	25.02%	25.26%	23.94%	28.50%	29.27%	27.90%	27.39%	29.25%
	8.63	9.52	4.99	1.18	-22.95	6.38	1.75	-12.05	26.69	3.13
Interest	24.20	23.74	25.55	11.75	14.49	18.78	15.67	10.68	13.66	12.10
	26.63	27.11	28.28	28.81	28.79	28.92	29.82	30.36	30.62	35.20
	27.71	28.68	36.77	41.61	15.27	49.58	64.43	60.85	120.44	98.05
	11.59%	50.97%	51.20%	23.61%	4.98%	5.45%	31.60%	26.74%	10.50%	-2.89%
	24.50	14.06	17.94	31.78	14.51	46.88	44.07	44.58	107.79	100.88
	2.82	1.44	1.83	3.25	1.48	4.79	4.51	2.28	5.51	5.16

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	1,145.52	1,050.11	1,151.60	1,286.43	1,538.87
	1,145.52	1,050.11	1,151.60	1,286.43	1,538.87
EXPENDITURE :
Increase/Decrease in Stock	-7.02	14.98	-34.78	37.62	-36.22
Raw Material Consumed	390.24	401.06	429.01	359.75	479.08
Power & Fuel Cost	52.43	56.79	52.41	53.74	59.24
Employee Cost	264.49	286.39	281.39	292.71	334.88
Other Manufacturing Expenses	120.03	110.32	95.70	122.62	161.53
General and Administration Expenses	71.58	46.86	43.99	59.03	77.53
Selling and Distribution Expenses	29.36	18.56	21.42	26.52	46.60
Miscellaneous Expenses	27.22	26.89	26.96	28.19	35.34
	948.32	961.84	916.10	980.18	1,157.98
Operating Profit (Excl OI)	197.20	88.27	235.51	306.25	380.89
	20.90	31.41	17.16	36.45	63.65
	218.10	119.68	252.66	342.70	444.54
Interest	41.17	58.65	91.80	75.53	58.79
PBDT	176.94	61.03	160.86	267.17	385.75
	79.80	95.50	107.87	112.99	119.72
Profit Before Taxation & Exceptional Items	97.13	-34.47	52.99	154.18	266.03
Exceptional Income / Expenses	8.79		6.13	-30.58	12.16
	102.26	-38.28	54.34	122.33	295.31
Provision for Tax	41.68	-7.36	22.39	44.04	51.98
	60.58	-30.92	31.96	78.29	243.33
Extra items				0.00	0.00
Minority Interest	0.08	-1.56	-0.08
Consolidated Net Profit	60.66	-32.48	31.87	78.29	243.33
Profit Balance B/F	991.51	1,043.20	1,001.18	1,033.85	1,087.57
Appropriations	1,052.17	1,010.73	1,033.05	1,112.14	1,330.90
Equity Dividend %	110.00%			100.00%	60.00%
	6.99	-3.74	3.67	8.01	12.44
Adjusted EPS	3.49	-1.87	1.84	4.00	12.44

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	8.68	8.68	8.68	9.78	19.56
Total Reserves	1,813.51	1,774.60	1,800.01	2,352.92	2,571.64
Reserve excluding Revaluation Reserve	1,813.51	1,774.60	1,800.01	2,352.92	2,571.64
Revaluation reserve		0.00
	1,822.19	1,783.28	1,808.69	2,362.70	2,591.20
Minority Interest	-11.05	-8.92	-8.74	1.04
Secured Loans	353.49	242.92	560.16	231.96	183.81
Unsecured Loans	0.11	45.90
Deferred Tax Assets / Liabilities	54.74	14.05	-10.26	-12.97	-16.89
Other Long Term Liabilities	25.40	24.60	17.11	15.25	49.34
Long Term Provisions	19.08	17.65	22.43	25.54	33.20
Total Non-Current Liabilities	452.82	345.12	589.44	259.78	249.46
Trade Payables	146.04	142.80	174.15	104.91	142.47
Other Current Liabilities	240.13	276.56	138.05	213.19	252.92
Short Term Borrowings	202.90	344.17	360.73	306.81	411.56
Short Term Provisions	22.46	20.92	20.66	49.28	41.11
Total Current Liabilities	611.54	784.45	693.59	674.19	848.06
Total Liabilities	2,875.50	2,903.93	3,082.98	3,297.71	3,688.72
Gross Block	1,727.09	1,846.68	1,946.75	2,076.00	2,358.98
Less: Accumulated Depreciation	385.25	478.35	561.89	658.16	765.86
	1,341.84	1,368.33	1,384.86	1,417.84	1,593.12
	190.04	358.04	403.00	462.52	431.20
Non Current Investments	34.23	42.66	39.91	34.54	57.94
Long Term Investment	34.23	42.66	39.91	34.54	57.94
Long Term Loans & Advances	93.90	56.53	53.32	37.71	42.67
Other Non Current Assets	12.15	11.52	9.87	1.34	1.17
Total Non-Current Assets	1,988.30	2,134.37	2,206.74	2,313.20	2,578.95
Inventories	355.24	319.82	344.93	347.93	366.79
Sundry Debtors	386.33	324.35	392.05	440.79	518.85
Cash and Bank	34.11	21.56	31.77	28.57	45.18
Other Current Assets	9.36	15.53	16.28	17.59	19.38
Short Term Loans and Advances	102.16	88.29	91.22	149.63	159.57
Total Current Assets	887.19	769.55	876.24	984.51	1,109.77
Net Current Assets (Including Current Investments)	275.66	-14.89	182.65	310.32	261.71
Total Assets	2,875.50	2,903.93	3,082.98	3,297.71	3,688.72
	103.86	186.39	100.40	76.22	160.01
Total Debt	681.91	797.04	935.59	586.37	657.97
	209.93	205.44	208.37	241.58	132.47
Adjusted Book Value	104.96	102.72	104.19	120.79	132.47

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	102.26	-38.28	54.34	122.33	295.31
Adjustment	109.34	147.81	221.44	195.05	142.45
Changes In working Capital	-71.99	102.77	-97.92	-138.09	-35.17
Cash Flow after changes in Working Capital	139.62	212.30	177.86	179.29	402.59
Cash Flow from Operating Activities	105.13	179.92	136.67	132.27	342.18
Cash Flow from Investing Activities	-285.50	-232.61	-166.58	-199.13	-325.92
Cash Flow from Financing Activitie	82.86	45.80	46.78	62.65	13.62
Net Cash Inflow / Outflow	-97.51	-6.89	16.86	-4.21	29.88
Opening Cash & Cash Equivalents	122.85	25.62	19.07	31.76	28.57
Effect of Foreign Exchange Fluctuations		0.34	-4.18	1.02	-13.27
Closing Cash & Cash Equivalent	25.34	19.07	31.76	28.57	45.18

Ratios

Valuation

62.80

6.95

39.69

11.10

15.20

137.34

Profitability

9.82

11.43

6.97

24.75

15.81

Leverage & Liquidity

0.25

1.31

6.02

Returns

0.06

0.44

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	44.39	44.33	44.23	44.23	44.23	44.23	40.13	40.13	40.13	40.13
	16.69	17.76	18.17	18.52	18.64	18.57	19.30	19.66	19.43	20.37
	38.92	37.90	37.60	37.25	37.13	37.20	40.56	40.21	40.43	39.49
	55.61	55.67	55.77	55.77	55.77	55.77	59.87	59.87	59.87	59.87
No. of Shareholders	41,072	42,784	49,034	50,108	48,636	52,065	53,799	53,410	60,926	87,477

Mutual Funds Invested(30)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 21 active funds hold 4.05% in Shilpa Medicare Ltd., contributing to ₹830 Cr of holdings

Fund				As of
ID Bandhan Small Cap Fund - Growth - Direct PlanSmall cap Fund	214.63	0.60	20,49,541	Sep '26
IP ICICI Prudential ELSS - Tax Saver Fund - Growth - Direct PlanEquity - ELSS - Tax Saver Fund	190.03	1.41	18,14,657	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	113.18	3.23	10,80,751	Sep '26
AB Aditya Birla Sun Life Small Cap Fund - Growth - Direct PlanSmall cap Fund	58.02	0.95	5,54,077	Sep '26
TR TRUSTMF Small Cap Fund - Growth - Direct PlanSmall cap Fund	38.22	0.99	3,65,016	Sep '26
MO Motilal Oswal Nifty Microcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	33.11	1.37	3,16,154	Sep '26
AB Aditya Birla Sun Life Manufacturing Equity Fund - Growth - Direct PlanEquity - Thematic Fund - Other	32.97	2.38	3,14,865	Sep '26
WC WhiteOak Capital Mid Cap Fund - Growth - Direct PlanMid Cap Fund	30.59	0.41	2,92,082	Sep '26
UN Union Small Cap Fund - Growth - Direct PlanSmall cap Fund	24.90	0.91	2,37,777	Sep '26
IP ICICI Prudential Exports and Services Fund - Growth - Direct PlanService Industry	24.69	1.70	2,35,800	Sep '26

Corporate Actions

Showing: All

Date	Type	Details
2026-10-29	Board Meeting	Quarterly Results
2026-08-14	AGM
2026-07-29	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-09-29	Alpesh Maheshkumar Dalal	Market	Sell	4,000

Sector Overview

HealthcarePharmaceuticals & Drugs

Shilpa Medicare Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Ritu Tiwary

Company Secretary & Compliance Officer

—

Omprakash Inani

Chairman

₹4.50 L

Mar '26

Vishnukant Bhutada

Managing Director

₹3.50 Cr

Mar '26

Sharath Reddy Kalakota

Whole Time Director

₹2.00 Cr

Mar '26

Kalakota Sharath Reddy

Whole Time Director

₹1.80 Cr

Mar '25

Hetal Madhukant Gandhi

Non Executive Independent Director

₹60.00 L

Mar '26

Anita Bandyopadhyay

Non Executive Independent Woman Director

₹18.00 L

Mar '26

Ashraf Loutfy Abdelhamid Allam

Non Executive Independent Director

₹22.20 L

Mar '26

SHILPAMED Latest News

News

10 of 10 articles

EQUITY12 Oct 2026 · 14:06

Shilpa Medicare moves up on getting GMP Certification from AGES, Austria for Telangana facility

AGES, Austria had conducted inspection at the said facility from July 27, 2026 to July 30, 2026

COMPANY12 Oct 2026 · 12:59

Shilpa Medicare gets GMP Certification from AGES, Austria for Telangana facility

AGES, Austria had conducted inspection at the said facility from July 27, 2026 to July 30, 2026

EQUITY11 Sept 2026 · 15:03

Shilpa Medicare rises on getting SEC’s final approval for OERIS

OERIS will be launched in India and enjoys patent protection in India until 2039

COMPANY11 Sept 2026 · 14:50

Shilpa Medicare gets SEC’s final approval for OERIS

OERIS will be launched in India and enjoys patent protection in India until 2039

EQUITY10 Sept 2026 · 17:40

Shilpa Medicare informs about initiation of NCLT order on FTF Pharma

EQUITY3 Aug 2026 · 11:47

Shilpa Medicare informs about appointment of CEO

EQUITY29 Jul 2026 · 16:23

Shilpa Medicare informs about board meeting

EQUITY30 Jun 2026 · 12:29

Shilpa Medicare informs about disclosure

COMPANY24 Jun 2026 · 09:58

Shilpa Medicare’s arm commissions Antibody-Drug Conjugate GMP manufacturing facility

This commissioning marks a significant evolution of Shilpa Medicare’s over 25 years of deep-rooted expertise in highly potent compound manufacturing

EQUITY24 Jun 2026 · 09:39

Shilpa Medicare informs about press release

Shilpa Medicare Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(30)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

SHILPAMED Latest News

News